Hilton Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,052
Closed -$1.36M 172
2025
Q1
$1.36M Buy
9,052
+1,014
+13% +$170K 0.12% 118
2024
Q4
$1.48M Buy
8,038
+380
+5% +$73.2K 0.13% 110
2024
Q3
$1.51M Buy
7,658
+1,135
+17% +$236K 0.12% 110
2024
Q2
$1.35M Buy
6,523
+163
+3% +$36.9K 0.11% 112
2024
Q1
$1.72M Buy
6,360
+3,571
+128% +$853K 0.15% 98
2023
Q4
$659K Buy
+2,789
New +$548K 0.07% 101
2021
Q4
Sell
-500
Closed -$206K 128
2021
Q3
$206K Sell
500
-84
-14% -$34.9K 0.02% 119
2021
Q2
$216K Buy
+584
New +$195K 0.02% 115
2021
Q1
Sell
-813
Closed -$203K 126
2020
Q4
$203K Sell
813
-315
-28% -$75K 0.02% 96
2020
Q3
$255K Sell
1,128
-260
-19% -$54K 0.03% 67
2020
Q2
$242K Buy
+1,388
New +$222K 0.03% 70
2020
Q1
Sell
-1,451
Closed -$222K 65
2019
Q4
$222K Buy
1,451
+537
+59% +$74.4K 0.03% 97
2019
Q3
$121K Buy
914
+168
+23% +$22.5K 0.02% 141
2019
Q2
$106K Sell
746
-66
-8% -$8.95K 0.01% 155
2019
Q1
$118K Buy
+812
New +$107K 0.02% 146

Other funds holding CRL

Hilton Capital Management's CRL Position: Q2 2025 in Review

Hilton Capital Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 9,052 shares — an estimated $1.36M sold.

Hilton Capital Management first reported a position in CRL in Q1 2019 and held it in 15 quarters. The position peaked at $1.72M in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Hilton Capital Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Hilton Capital Management sold 9,052 Charles River Laboratories shares in Q2 2025, an estimated $1.36M.
  • Hilton Capital Management first reported a position in Charles River Laboratories in Q1 2019 and held it in 15 quarters.
  • Hilton Capital Management's Charles River Laboratories position peaked at $1.72M in Q1 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Hilton Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.